At Epic’s customer meeting STAT reports CEO Judy Faulkner announced new AI features—including a Microsoft-powered AI scribe and assistants for clinicians, patients, and staff—reflecting Epic’s hold on more than 40% of the hospital EHR market. A Williams Institute analysis estimates 2.8 million U.S. residents age 13+ identify as transgender (3.3% of 13–17-year-olds; 0.8% of adults), but the piece notes the CDC has said it will no longer process transgender-identity data. A brain-imaging study of three people before and six months after hand amputation found preserved body maps, potentially altering prosthesis and therapy approaches. STAT’s Jason Mast documents the fallout from Sarepta’s shift away from long-term limb‑girdle muscular dystrophy gene-therapy commitments as it pursued Duchenne treatments, leaving families devastated. Controversy swirled as newly appointed ACIP member Robert Malone declared he no longer trusts CDC summaries after critiquing an RSV monoclonal antibody analysis; ACOG affirms monoclonal antibodies as safe for infants. Finally, STAT examines how new cardiovascular risk equations complicate statin-threshold decisions, with a JAMA Cardiology letter detailing threshold impacts.